This episode of Pharma Pulse discusses a new executive order to build a domestic API stockpile, Eli Lilly’s 170% price ...

As over half of Americans now receive prescriptions through Medicare or Medicaid, pharma companies must shift from a commercial-first approach to a statutory-first model, making GTN governance a ...

The directive calls for building a six-month Strategic Active Pharmaceutical Ingredients Reserve, updating the essential ...

Two Labs’ Michael Rowe assesses the industry’s level of preparation, including challenges stakeholders have encountered along ...

In the second part of his Pharma Commerce video interview, Dave Malenfant, a healthcare supply chain expert, outlines how the impact of a steep pharmaceutical import tariff varies across raw materials ...